Browsing by Subject "C12N 15/113"

Now showing items 1-3 of 3

    • Angelman syndrome antisense treatment 
      Dindot, Scott Victor (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-12-14)
      Disclosed herein are antisense oligonucleotides that are capable of inducing expression of ubiquitin-protein ligase E3A (UBE3A) from the paternal allele in animal or human neurons. The oligonucleotides target the suppressor ...
    • Cancer treatment targeting non-coding RNA overexpression 
      Safe, Stephen; Kim, Kyounghyun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-02-17)
      Provided herein are methods directed to modulating the pro-oncogenic effects of noncoding RNAs (ncRNAs) through their interactions with specificity protein transcription factors (SpTFs). In one aspect, the disclosure ...
    • Methods and products for treating preeclampsia and modulating blood pressure 
      Newell-rogers, Martha Karen; Mitchell, Brett; Newell, Evan (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-06-07)
      The invention relates to methods for altering biological parameters in a subject, such as reducing blood pressure in a subject, by displacing CLIP, using a CLIP inhibitor. The methods are useful for treating disorders such ...